Doctors say Medicaid change to gender-affirming care will harm vulnerable youth
Federal Medicaid dollars can no longer pay for gender-affirming care for youth. Doctors who treat trans kids say it will harm vulnerable people.
Read full article →Medicare Monitor
Tracking Medicare news, policy, and coverage changes.
Providence reports $400M operating improvement halfway through 2026
The major nonprofit system has logged its fourth consecutive quarter of operating gains after years in the red—a key milestone for its leaders ahead of OBBBA's expected headwinds.
Read full article →Major PBMs agree to offer TrumpRx pricing information to members
The Pharmaceutical Care Management Association announced Thursday that its members had reached an agreement with the feds to offer information on cash prices available through TrumpRx.
Read full article →Appeals Court Sides with Providers in No Surprises Act Pay Dispute
A court ruling struck down key parts of how regulators calculate the No Surprises Act’s qualifying payment amount, siding with the Texas Medical Association’s argument that the formula has historically favored payers in arbitration. The post Appeals Court Sides with…
Read full article →Cotiviti Launches AI Solution to Address Coordination of Benefits Issues
Cotiviti launched an AI-powered coordination of benefits solution that uses enrollment data to identify and resolve coverage issues before claims are submitted. The post Cotiviti Launches AI Solution to Address Coordination of Benefits Issues appeared first on MedCity News .
Read full article →PTC Therapeutics’ $211M Bid Wins Bankruptcy Auction for Sangamo Gene Therapy
Sangamo Therapeutics filed for Chapter 11 bankruptcy in June after its search for strategic alternatives failed to find a path forward for the company. PTC Therapeutics’ auction win brings a Sangamo gene therapy candidate for Fabry disease, a rare inherited…
Read full article →STAT+: Commure terminates payments under its customer referral programs tied to AI products
Commure, which develops and sells AI products to clinics, has terminated a program that paid for referrals to new customers.
Read full article →FDA Approves First CELMoD Drug for Multiple Myeloma
(MedPage Today) -- The FDA granted accelerated approval to the first cereblon E3 ligase modulation (CELMoD) therapy for relapsed or refractory multiple myeloma, the agency announced on Thursday. An oral drug, iberdomide (Zenbexus) is approved...
Read full article →Luigi Mangione Expected to Plead Guilty in UnitedHealthcare CEO Killing, Source Says
(MedPage Today) -- Luigi Mangione is expected to plead guilty as early as Friday in the federal case accusing him of stalking and killing UnitedHealthcare CEO Brian Thompson, according to a person familiar with the matter. The person, who was...
Read full article →Preoperative GLP-1s Don't Diminish Bariatric Surgery Results, Study Suggests
(MedPage Today) -- Bariatric surgery patients who took GLP-1 medications prior to surgery lost the same amount of weight after 1 year as individuals unexposed to the blockbuster class of drugs, a retrospective review indicated. Among 383 patients...
Read full article →Researchers Try to Tie Cannabis to Irregular Heartbeats, Opposite Turns Out True
(MedPage Today) -- Defying expectations, regular cannabis users had fewer ectopic heartbeats on the days they reached for the joint or vape, a randomized crossover trial showed. On days using cannabis, there was a significant 9% reduction in these...
Read full article →JAK Inhibitor Might Be the Most Effective One Yet for Severe Alopecia
(MedPage Today) -- The JAK inhibitor upadacitinib (Rinvoq) dramatically improved hair regrowth for patients with severe alopecia areata in two parallel phase III trials, with results that appeared better than previously seen among the class of...
Read full article →